Solid Non Operating Income Net Other from 2010 to 2026
| SLDB Stock | USD 5.71 0.17 2.89% |
Non Operating Income Net Other | First Reported 2010-12-31 | Previous Quarter 23.5 M | Current Value 24.7 M | Quarterly Volatility 9.6 M |
Check Solid Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Solid Biosciences' main balance sheet or income statement drivers, such as Interest Income of 11.4 M, Depreciation And Amortization of 2.1 M or Interest Expense of 371.4 K, as well as many indicators such as Price To Sales Ratio of 10.66, Dividend Yield of 0.0 or PTB Ratio of 1.12. Solid financial statements analysis is a perfect complement when working with Solid Biosciences Valuation or Volatility modules.
Solid | Non Operating Income Net Other | Build AI portfolio with Solid Stock |
Analyzing Solid Biosciences's Non Operating Income Net Other over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Non Operating Income Net Other has evolved provides context for assessing Solid Biosciences's current valuation and future prospects.
Latest Solid Biosciences' Non Operating Income Net Other Growth Pattern
Below is the plot of the Non Operating Income Net Other of Solid Biosciences LLC over the last few years. It is Solid Biosciences' Non Operating Income Net Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Solid Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Non Operating Income Net Other | 10 Years Trend |
|
Non Operating Income Net Other |
| Timeline |
Solid Non Operating Income Net Other Regression Statistics
| Arithmetic Mean | 7,694,434 | |
| Geometric Mean | 2,873,941 | |
| Coefficient Of Variation | 124.14 | |
| Mean Deviation | 8,376,613 | |
| Median | 2,095,000 | |
| Standard Deviation | 9,551,980 | |
| Sample Variance | 91.2T | |
| Range | 24.7M | |
| R-Value | 0.77 | |
| Mean Square Error | 39.1T | |
| R-Squared | 0.60 | |
| Significance | 0.0003 | |
| Slope | 1,462,528 | |
| Total Sum of Squares | 1459.8T |
Solid Non Operating Income Net Other History
About Solid Biosciences Financial Statements
Solid Biosciences stakeholders use historical fundamental indicators, such as Solid Biosciences' Non Operating Income Net Other, to determine how well the company is positioned to perform in the future. Although Solid Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Solid Biosciences' assets and liabilities are reflected in the revenues and expenses on Solid Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Solid Biosciences LLC. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Non Operating Income Net Other | 23.5 M | 24.7 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Solid Biosciences LLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Solid Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Solid Biosciences Llc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Solid Biosciences Llc Stock:Check out the analysis of Solid Biosciences Correlation against competitors. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Solid Biosciences. If investors know Solid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Solid Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Solid Biosciences LLC requires distinguishing between market price and book value, where the latter reflects Solid's accounting equity. The concept of intrinsic value - what Solid Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Solid Biosciences' price substantially above or below its fundamental value.
Please note, there is a significant difference between Solid Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Solid Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Solid Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.